A no-brainer S&P 500 stock to buy and hold for the next decade?

This S&P 500 monopoly stock may not be cheap, but its long-term potential more than justifies its premium valuation. Can it continue to dominate?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Overall, S&P 500 stocks have been on a stellar run throughout 2024. The US’s flagship index is up 27% since the start of January, or 29% including dividends. Yet some of its constituents have fared far better, including Intuitive Surgical (NASDAQ:ISRG).

The robotic-assisted surgery specialist has climbed by over 60% this year. Sceptics have been arguing that the firm’s big performance is only being driven by a backlog of delayed procedures created by the pandemic.

However, with each passing quarter, the company seems to be disproving this claim. In fact, it’s now beaten earnings expectations seven times in a row. That’s almost two years of consistent outperformance, resulting in a doubling of its share price. And yet, this might only be the tip of the iceberg.

Should you invest £1,000 in Rolls-Royce right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Rolls-Royce made the list?

See the 6 stocks

The global leader in surgical robotics

Adoption of robot-assisted surgery has been relatively slow over the last 20 years. The technology’s expensive and most health insurance providers prefer covering the cheaper, traditional surgical procedures. However, this is a story that’s been slowly changing.

The cost’s still high. But it’s been falling steadily. And as an early mover within this burgeoning market, Intuitive Surgical’s now the global leader, with an estimated 50-80% market share worldwide. Its Da Vinci Surgical System seems to have become an industry standard, with hospitals and clinics adding it to their portfolio of medical equipment and investing time in training surgeons to use it.

Da Vinci’s currently the core of Intutitive’s business model, with a continued 18% jump in procedures in its latest results. However, its new Ion System – a robotic minimally-invasive bronchoscopy solution – is seeing significantly faster procedure growth of 73%.

Given Intuitive operates with a razor-and-blade business model, more procedures mean more demand for its high-margin instruments, accessories, and consumables. And it’s a trend that doesn’t appear to be slowing anytime soon.

What could go wrong?

As impressive as Intuitive’s business appears, there are always risks for investors to consider. From a valuation perspective, this S&P 500 stock’s far from cheap. Limited competition grants management monopoly-like powers, resulting in staggering free cash flow generation as the robotic surgery market evolves. Even more so, given the risk of disruption from a new start-up, it seems unlikely due to the regulatory barriers to entry of the healthcare industry.

Needless to say, this advantage is pretty substantial, and it’s reflected in a premium valuation. But it also opens the door to volatility should performance fail to keep up with rising expectations.

It’s also important not to completely ignore established rivals. A tactic that’s being increasingly deployed by peers is creating systems for surgeries that Da Vinci and Ion simply can’t do yet. And once a surgeon’s been trained on these systems, convincing hospitals and doctors to invest time to retrain is a hard sell.

As such, a potential slowdown of R&D innovation is one of the biggest risks for this business, in my opinion. Having said that, the firm’s track record of defying expectations speaks for itself. And with the adoption of these technologies expected to continue rising for decades to come, this S&P 500 gem seems like a no-brainer for my portfolio even at a premium valuation.

I bought some of its shares recently and expect to buy more next month.

Should you invest £1,000 in Rolls-Royce right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Rolls-Royce made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian has positions in Intuitive Surgical. The Motley Fool UK has recommended Intuitive Surgical. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Modern suburban family houses with car on driveway
Investing Articles

Down 59% from its 12-month highs, is this FTSE 250 stock too cheap to ignore?

Shares in FTSE 250 housebuilder Vistry are almost certainly too cheap to ignore. But are they discounted enough to offset…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

As the S&P 500 struggles to recover, here’s what Warren Buffett’s doing

The S&P 500 is fighting to regain its February highs amid ongoing trade tariff uncertainty. Our writer looks to the…

Read more »

Investing Articles

When will Lloyds shares hit £1?

Lloyds shares have surged over the past 12 months, but where will they go next? Dr James Fox thinks there’s…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Stock-market crash: the meltdown of the Magnificent 7

Just before Christmas, these Magnificent Seven stocks were riding high. But after the worst quarter for US stocks since autumn…

Read more »

Investing Articles

Wow! IAG shares are undervalued by 47%, according to analysts

IAG shares have surged over the past 18 months, but analysts are pointing to more growth. Dr James Fox takes…

Read more »

Investing Articles

2 cheap FTSE 100 and FTSE 250 shares to consider for an ISA before 5 April!

These FTSE 100 and FTSE 250 shares are on sale today! Here's why long-term Stocks and Shares ISA investors should…

Read more »

Investing Articles

How I’m building a new second income for 2035

Millions of us invest for a second income. Here are the steps Dr James Fox is taking in order to…

Read more »

Investing Articles

At a 52-week low but forecast to rise 73%! Is this growth share the FTSE’s top recovery play? 

This FTSE 100 growth share has taken an absolute beating over the past two years but Harvey Jones says the…

Read more »